Shanghai Junshi Bioscienc... (SHJBF)

PNK: SHJBF · Real-Time Price · USD

1.97

0.67 (51.54%)

At close: May 01, 2025, 8:00 PM

Shanghai Junshi Biosciences Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	2.49B	3.78B	6.03B	3.5B	3.38B	1.21B	2.76B	266.3M	111.39M
Short-Term Investments	430.51M	284.00	1.2B	1.23B	17K	17K	5.52M	147.43M	373.47M
Long-Term Investments	795.9M	1.13B	201.62M	232.92M	64.67M	20.33M	2.77M	158.31K	37.43M
Other Long-Term Assets	892.45M	188.39M	1.58B	1.42B	525.28M	456.73M	327.86M	277.44M	393.24M
Receivables	509.82M	479.72M	238.19M	1.3B	664.44M	163.21M	n/a	220K	514K
Inventory	584.47M	538.05M	599.02M	484.6M	343.43M	180.67M	48.47M	30.6M	7.09M
Other Current Assets	272.34M	753.91M	377.87M	1.43B	680.23M	205.5M	92.63M	66.45M	53.69M
Total Current Assets	4.28B	5.55B	7.22B	5.83B	4.7B	1.91B	2.91B	511.01M	544.91M
Property-Plant & Equipment	4.62B	4.25B	3.02B	3.42B	2.67B	2.01B	1.01B	429.18M	171.76M
Goodwill & Intangibles	120.5M	134.42M	316.09M	51.83M	31.02M	6.29M	1.46M	1.78M	1.52M
Total Long-Term Assets	6.52B	5.81B	5.34B	5.22B	3.31B	2.51B	1.35B	708.7M	604.12M
Total Assets	10.8B	11.36B	12.56B	11.05B	8.01B	4.42B	4.26B	1.22B	1.15B
Account Payables	208.36M	247.26M	281.6M	196.21M	90.71M	74.62M	40.18M	16.31M	7.25M
Deferred Revenue	n/a	n/a	591.38K	7.18M	6.6M	416.94M	161.85K	99.23K	81.44K
Short-Term Debt	894.6M	539.39M	351.36M	10.6M	252.35M	76.89M	178.63M	n/a	n/a
Other Current Liabilities	1.06B	1.29B	730.95M	439.98M	466.29M	256.11M	98.88M	21.44M	4.8M
Total Current Liabilities	2.53B	2.48B	1.77B	2.02B	1.49B	605.38M	471.06M	58.56M	18.96M
Long-Term Debt	1.98B	1.2B	839.58M	490M	542.22M	744.9M	391.76M	n/a	n/a
Other Long-Term Liabilities	158.43M	333.86M	121.62M	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	2.32B	1.55B	1.02B	701.9M	677.02M	828.55M	465.11M	41.81M	3.45M
Total Liabilities	4.85B	4.02B	2.78B	2.72B	2.17B	1.43B	936.18M	100.38M	22.41M
Total Debt	2.93B	1.79B	1.24B	628.2M	850.78M	862.97M	570.39M	n/a	n/a
Common Stock	985.69M	985.69M	982.87M	910.76M	872.5M	784.15M	760.31M	584.75M	550M
Retained Earnings	-10.32B	-9.06B	-6.78B	-688.39M	-560.82M	-1.99B	-1.24B	-79.76M	-28.5M
Comprehensive Income	n/a	-142.07M	2.32B	1.9B	1.44B	707.36M	663.81M	252.02M	190.16M
Shareholders Equity	5.88B	7.17B	9.48B	7.96B	5.84B	2.99B	3.32B	1.12B	1.13B
Total Investments	1.23B	1.13B	1.4B	1.46B	422.9M	141.59M	19.03M	5.35M	222.9M